Inflammatory marker may highlight aggressive RCC treatment need
Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.
No comments:
Post a Comment